Antioxidants

Edaravon

Products For ALS treatment, edaravone was approved in Japan in 2015 (Radicut) and in the United States in 2017 as an infusion product (Radicava). In the EU, edaravone has orphan drug status. In many countries, the drug has been registered since 2019. Structure and properties Edaravone (C10H10N2O, Mr = 174.2 g/mol) is a substituted 2-pyrazolin-5-one. … Edaravon

Ethoxyquin

Products Ethoxyquin was synthesized in the 1920s. In the late 1950s, ethoxyquin was first marketed by Monsanto (Santoquine). It is available as a chemical, among other products. Structure and properties Ethoxyquin (C14H19NO, Mr = 217.3 g/mol) is an ethoxy derivative of a methylated quinoline. It exists as a yellow liquid that turns brown when exposed … Ethoxyquin